Noevir Holdings Co Ltd
TSE:4928
Noevir Holdings Co Ltd
Income from Continuing Operations
Noevir Holdings Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Noevir Holdings Co Ltd
TSE:4928
|
Income from Continuing Operations
¥7.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
Shiseido Co Ltd
TSE:4911
|
Income from Continuing Operations
¥21.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-3%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Income from Continuing Operations
¥31.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
26%
|
CAGR 10-Years
13%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Income from Continuing Operations
¥9.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
Income from Continuing Operations
¥58.1B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-3%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Income from Continuing Operations
¥17.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
See Also
What is Noevir Holdings Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
7.6B
JPY
Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Income from Continuing Operations amounts to 7.6B JPY.
What is Noevir Holdings Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
5%
Over the last year, the Income from Continuing Operations growth was -5%. The average annual Income from Continuing Operations growth rates for Noevir Holdings Co Ltd have been 12% over the past three years , -2% over the past five years , and 5% over the past ten years .